Lack of clinical trial participants could slow progress for Alzheimer’s and Dementia research, report says

Global News

A shortage of clinical trial participants could slow down progress for Alzheimer's and dementia research, according to a new report from Alzheimer's Disease International. The organization says there are currently 158 potential therapies being evaluated across more than 190 global trials.

Video Runtime: 2:21